Amerikanische Gesellschaft für Hirudotherapie

Digital replantation/revascularization: predictive factors to microsurgery success - a single-center study

Retrospective study published in Eur J Trauma Emerg Surg (2019)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studyKlinische StudienTejedor Navarro A et al. · European journal of trauma and emergency surgery, 2019

Abstract

PURPOSE: Success rate in replantation/revascularization digital surgery is one of the challenges of reconstructive surgery. For this reason, investigating prognostic factors for survival and improvement of outcomes is highly relevant. The goal of this study was to establish predictive factors of survival in replantation/revascularization digital surgery. METHODS: A descriptive, retrospective study was performed in patients who underwent urgent replantation/revascularization digital surgery in our center between January 2007 and July 2017. A total of 116 patients and 157 digits were included. Outcome (survival) factors evaluated were: preoperatively: age, sex, body mass index (BMI), ASA anesthesia score, comorbidities (smoking status, diabetes mellitus, hypertension), coagulation, type of lesion, number of affected digits, position of affected digits, injury mechanism, ischemia time; time between accident and the surgery; intraoperatively: anesthetic technique, fluid therapy (administered volume), length of surgery; and postoperatively: post-surgical complications, re-intervention requirements, surgical success rate. Statistical analysis was performed to evaluate outcome and elicit predictive factors. RESULTS: 157 digits from a total of 116 patients were included. Statistically significant differences regarding predictors of survival of replantation were found in ischemia time (0 0.003), length of surgery (p 0.004), post-surgical complications (p 0.000) and replantation need (p 0.000). The rest of analyzed variables were not statistically significant (p > 0.05). Revascularization surgery had a greater success rate than replantation (p 0.001). CONCLUSIONS: Success rate in traumatic digital surgery is greater when revascularization surgery is performed, rather than replantation. Preoperative ischemia time, length of surgery, postoperative complications and re-intervention requirement are the factors that affect survival rate.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleObservational Study
Indexed MeSH termsAdultFemaleFinger InjuriesGraft SurvivalHumansMaleMicrosurgeryMiddle AgedOperative TimePostoperative ComplicationsPrognosisReplantation

Zusammenfassung

10-year retrospective study of 157 digits in 116 patients identifying ischemia time, surgery length, and postoperative complications as predictors of digital replant/revascularization success. Revascularization > replantation.

Warum dies für die Hirudotherapie relevant ist

This single-center retrospective observational study (116 patients, 157 digits) identified ischemia time, length of surgery, post-surgical complications, and replantation (versus revascularization) need as significant predictors of digit survival after replantation or revascularization, with revascularization showing higher success. The relevance to ASH's domain is indirect: this study concerns prognostic factors in digital microsurgery, a setting where medicinal leeches are sometimes used to manage venous congestion, but leeches are not mentioned. No data on leech therapy, the secretome, or venous-congestion adjuncts are provided. The study is retrospective and single-center, limiting generalizability, and offers no direct evidence relevant to hirudotherapy practice.

Zitation

Digital replantation/revascularization: predictive factors to microsurgery success - a single-center study.

Tejedor Navarro A et al. · European journal of trauma and emergency surgery, 2019

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.